Literature DB >> 19191628

Childhood bacterial meningitis in Ulaanbaatar, Mongolia, 2002-2004.

Jamsran Mendsaikhan1, James P Watt, Osman Mansoor, Nyam Suvdmaa, Karen Edmond, David J Litt, Pagvajav Nymadawa, Yang Baoping, Dorjpurev Altantsetseg, Mary Slack.   

Abstract

BACKGROUND: Childhood bacterial meningitis is severe and largely preventable by vaccination. Few data on childhood bacterial meningitis in Northeast and Central Asia exist. Our aim was to determine the incidence and etiology of childhood bacterial meningitis in Ulaanbaatar, Mongolia.
METHODS: We conducted prospective, population-based, active hospital surveillance for clinical meningitis in children 2 months to 5 years of age. Clinical data, blood, and cerebrospinal fluid were collected according to a standard protocol. Laboratory testing was performed at 2 reference laboratories in Ulaanbaatar.
RESULTS: From February 2002 to January 2005, 201 suspected meningitis cases were identified in residents of Ulaanbaatar. The average annual incidence rate for confirmed and probable bacterial meningitis (cases with culture-negative, purulent cerebrospinal fluid) was 68 cases per 100,000 children aged 2 months to 5 years. The average annual incidence rate of confirmed cases was 28 cases per 100,000 children for Haemophilus influenzae type b meningitis, 11 cases per 100,000 children for pneumococcal meningitis, and 13 cases per 100,000 children for meningococcal meningitis. Adjusting for cases without complete cerebrospinal fluid information and culture-negative, probable bacterial cases, the estimated incidence rate was 40 cases per 100,000 children for H. influenzae type b meningitis, 15 cases per 100,000 children for pneumococcal meningitis, and 17 cases per 100,000 children for meningococcal meningitis.
CONCLUSION: H. influenzae type b is the leading cause of childhood bacterial meningitis in Ulaanbaatar, and the incidence rate is higher than that reported from other Asian countries. These data supported the recent introduction of H. influenzae type b conjugate vaccine in Mongolia. Ongoing surveillance will monitor the impact of the vaccine.

Entities:  

Mesh:

Year:  2009        PMID: 19191628     DOI: 10.1086/596493

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience.

Authors:  Rana Hajjeh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

Review 3.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

4.  The causative organisms of bacterial meningitis in Korean children in 1996-2005.

Authors:  Hye Kyung Cho; Hyunju Lee; Jin Han Kang; Kwang Nam Kim; Dong Soo Kim; Yun Kyung Kim; Jung Soo Kim; Jong-Hyun Kim; Chang Hwi Kim; Hwang Min Kim; Su-Eun Park; Sung Hee Oh; Eun Hee Chung; Sung Ho Cha; Young Youn Choi; Jae Kyun Hur; Young Jin Hong; Hoan Jong Lee; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

5.  Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Authors:  Andrew D Clark; Ulla K Griffiths; Syed Shahid Abbas; Krishna D Rao; Lois Privor-Dumm; Rana Hajjeh; Hope Johnson; Colin Sanderson; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

Review 6.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

7.  Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan.

Authors:  Ulla K Griffiths; Andrew Clark; Veronika Shimanovich; Irina Glinskaya; Dilorom Tursunova; Lucia Kim; Liudmila Mosina; Rana Hajjeh; Karen Edmond
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

8.  Meningococcal disease serogroup C.

Authors:  Félix O Dickinson; Antonio E Pérez; Iván E Cuevas
Journal:  Risk Manag Healthc Policy       Date:  2012-03-08

9.  Global epidemiology of invasive meningococcal disease.

Authors:  Rabab Z Jafri; Asad Ali; Nancy E Messonnier; Carol Tevi-Benissan; David Durrheim; Juhani Eskola; Florence Fermon; Keith P Klugman; Mary Ramsay; Samba Sow; Shao Zhujun; Zulfiqar A Bhutta; Jon Abramson
Journal:  Popul Health Metr       Date:  2013-09-10

10.  High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in cerebrospinal fluid samples from patients with purulent meningitis.

Authors:  Aicui Liu; Chao Wang; Zhijuan Liang; Zhi-Wei Zhou; Lin Wang; Qiaoli Ma; Guowei Wang; Shu-Feng Zhou; Zhenhai Wang
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.